News related to Kaletra (Lopinavir / Ritonavir) and/or conditions it is approved for
Preventing HIV infection with prophylactic drugs important to reversing HIV epidemic among men who have sex with men in the UK
Source: HIV / AIDS News From Medical News Today [2016.01.14]
The use of antiretroviral therapy (ART) taken as pre-exposure prophylaxis (PrEP)1 could lead to a marked decline in HIV incidence - the annual rate of infection - among men who have sex with men...
Study shows direct link between state spending habits and AIDS deaths
Source: HIV / AIDS News From Medical News Today [2016.02.04]
Despite considerable advances in the prevention and treatment of HIV/AIDS over the past 30 years, HIV infection rates have remained stagnant in the United States for the past decade.
HIV vaccines produce significant immune response in randomized trial
Source: HIV / AIDS News From Medical News Today [2016.02.01]
According to a randomized trial published in Annals of Internal Medicine, two novel vaccines for the prevention of HIV-1 produced significant immune response in healthy adults without HIV infection.
Pre-exposure prophylaxis, used to prevent HIV, found to be as safe as aspirin
Source: HIV / AIDS News From Medical News Today [2016.01.20]
Pre-exposure prophylaxis, or PrEP, is the first medicine approved by the Food and Drug Administration that has been shown to be effective for preventing HIV infection.